Channels: Retina | Posted 12/4/2012
Michael Singer, MD, and Joshua Singer of the Medical Center Ophthalmology Associates in San Antonio, Texas demonstrates the new, sharper needle for the Ozurdex (dexamethasone intravitreal implant) 0.7 mg injection system. It compares it to the original needle, and shows how the new needle changes the experience for the patient, the staff and the doctor. To view the original video, click here.
Branch retinal vein occlusion, BRVO • Central retinal vein occlusion, CRVO • Posterior noninfectious uveitis • Therapeutic drug delivery • Therapeutics